Elevance Health Inc (ELV)

Currency in USD
419.24
+4.83(+1.16%)
Real-time Data·
ELV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
417.51422.56
52 wk Range
274.84450.69
Key Statistics
Prev. Close
414.41
Open
421.3
Day's Range
417.51-422.56
52 wk Range
274.84-450.69
Volume
586.12K
Average Volume (3m)
1.15M
1-Year Change
24.6284%
Book Value / Share
206.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
482.38
Upside
+15.06%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 16 consecutive years

Elevance Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

14 Buy
8 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 482.38
(+15.06% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Buy492.00+17.44%473.00Maintain27-10-2026
Bernstein SocGen Group
Buy520.00+24.12%488.00Maintain23-10-2026
TD Cowen
Buy495.00+18.16%465.00Maintain23-10-2026
Mizuho
Buy490.00+16.96%470.00Maintain23-10-2026
UBS
Buy523.00+24.84%460.00Maintain22-10-2026

Elevance Health Inc SWOT Analysis


Resilient Amid Headwinds
Elevance Health navigates Medicaid challenges while maintaining strong market position and growth potential in specialty sales and other segments
Strategic Expansion
Delve into Elevance's recent acquisitions in specialty pharmacy, positioning the company for significant growth and vertical integration
Financial Outlook
Analysts project EPS of $37.31 for the current fiscal year, with an average price target of $599, indicating confidence in future performance
Industry Dynamics
Explore how Elevance adapts to healthcare trends, including Medicaid redetermination and Medicare cost management, shaping its competitive edge
Read full SWOT analysis

Elevance Health Inc Earnings Call Summary for Q3/2026

  • Elevance Health Q3 2026 adjusted EPS of $6.99 beat estimates by 48.7%; revenue of $50.4B topped forecasts by 2.2%, though stock fell 1.23% pre-market.
  • Company raised 2026 adjusted EPS guidance to at least $29 and operating cash flow outlook to at least $6.5B; reaffirmed 12% EPS growth target for 2027.
  • Benefit expense ratio improved 70 basis points to 90.6% with outperformance across Medicaid, Medicare Advantage, and individual ACA businesses.
  • $1.85 per share of Q3 beat came from favorable non-operating items including investment valuation adjustments, raising investor concerns about repeatability.
  • Management expects continued margin improvement in Medicare Advantage (targeting 3-5% long-term) and Medicaid as state rate alignment progresses in 2027.
Last Updated: 21-10-2026, 07:12 pm
Read Full Transcript

Earnings

Latest Release
21-10-2026
EPS / Forecast
6.99 / 4.70
Revenue / Forecast
50.4B / 49.32B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.51
Dividend Yield
1.66%
Industry Median 1.95%
Annualised payout
6.88
Paid quarterly
5-Years Growth
+9.62%
Growth Streak

ELV Income Statement

Compare ELV to Peers and Sector

Metrics to compare
ELV
Peers
Sector
Relationship
P/E Ratio
17.6x11.3x−0.3x
PEG Ratio
−4.470.310.00
Price/Book
2.0x2.0x2.6x
Price / LTM Sales
0.4x1.0x2.9x
Upside (Analyst Target)
16.4%12.3%60.1%
Fair Value Upside
Unlock5.0%8.3%Unlock

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
108.29M50.12%44.88B
Other Institutional Investors
98.97M45.81%41.02B
Public Companies & Retail Investors
8.79M4.07%3.64B
Total
216.06M100.00%89.54B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.79%1,89,91,09078,70,098
Vanguard Capital Management, LLC7.06%1,52,51,54063,20,391

FAQ

What Is the Elevance Health (ELV) Share Price Today?

The Elevance Health share price today is 419.24.

What is the current Elevance Health (ELV) share price and day range?

As of 29-10-2026, the Elevance Health share price is 419.24, with a previous close of 414.41. The share price has ranged from 417.51 to 422.56 today, while the 52-week range spans from 274.84 to 450.69.

What Is the Elevance Health Market Cap?

As of today, Elevance Health market cap is 90.54B.

Does Elevance Health Pay Dividends? What's The Current Dividend Yield?

The Elevance Health dividend yield is 1.7%%.

What Is the Elevance Health (ELV) Share Price Target?

The average 12-month share price target for Elevance Health is 482.38, with a high estimate of 523 and a low estimate of 406. 14 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +15.06% Upside potential.

What Is Elevance Health's Earnings Per Share (TTM)?

The Elevance Health EPS (TTM) is 23.51.

When Is the Next Elevance Health Earnings Date?

Elevance Health will release its next earnings report on 27-01-2027.

From a Technical Analysis Perspective, Is ELV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does Elevance Health Trade On?

Elevance Health is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Elevance Health?

The stock symbol for Elevance Health is "ELV."

How Many Times Has Elevance Health Stock Split?

Elevance Health has split 1 times.

How Many Employees Does Elevance Health Have?

Elevance Health has 96615 employees.

What Is the ELV Premarket Price?

ELV's last pre-market stock price is 406.81. The pre-market share volume is 590.00, and the stock has changed by -7.60, or -1.83%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.